Literature DB >> 21793128

Influence of age at diagnosis and sex on clinical course and long-term prognosis of intestinal Behcet's disease.

Yoon Suk Jung1, Jin Young Yoon, Sung Pil Hong, Tae Il Kim, Won Ho Kim, Jae Hee Cheon.   

Abstract

BACKGROUND: The aim of this study was to examine the influence of age at diagnosis and sex on the clinical course and long-term prognosis of intestinal Behcet's disease (BD).
METHODS: We reviewed the medical records of 291 patients with intestinal BD who underwent regular follow-up at a single tertiary academic medical center. The patients were divided into two groups according to their age at diagnosis of intestinal BD or sex. The cumulative probabilities of operation, admission, corticosteroid use, and immunosuppressant use after diagnosis were analyzed using the Kaplan-Meier method and a log-rank test.
RESULTS: Of the 291 patients, 154 (52.9%) were diagnosed with intestinal BD when younger than 40 years old, and 132 (45.4%) were male. Younger age at diagnosis was associated with a higher leukocyte count, C-reactive protein (CRP) level, and disease activity index for intestinal BD, and with a greater prevalence of volcano-shaped ulcers and a definite diagnostic subtype. Moreover, the cumulative probabilities of operation, admission, and corticosteroid use were significantly higher in the younger group. Male sex was associated with a higher CRP level and a greater prevalence of volcano-shaped ulcers. However, there were no significant differences in cumulative probabilities of operation, admission, corticosteroid use, and immunosuppressant use according to sex.
CONCLUSIONS: In intestinal BD, younger age at diagnosis is associated with a more severe clinical course and a poorer prognosis. However, although some clinical manifestations at initial diagnosis tend to be more severe in male patients, clinical outcomes do not differ significantly according to sex.
Copyright © 2011 Crohn's & Colitis Foundation of America, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21793128     DOI: 10.1002/ibd.21833

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  11 in total

1.  Peripheral arterial involvement in Behcet's disease: an analysis of the results from a Korean referral center.

Authors:  Shin-Seok Yang; Keun-Myoung Park; Yang Jin Park; Young-Wook Kim; Young Soo Do; Hong Suk Park; Kwang Bo Park; Dong-Ik Kim
Journal:  Rheumatol Int       Date:  2013-02-16       Impact factor: 2.631

Review 2.  Gastrointestinal Behçet's disease: a review.

Authors:  Wasseem Skef; Matthew J Hamilton; Thurayya Arayssi
Journal:  World J Gastroenterol       Date:  2015-04-07       Impact factor: 5.742

3.  Clinical course of intestinal Behcet's disease during the first five years.

Authors:  Yoon Suk Jung; Jae Hee Cheon; Soo Jung Park; Sung Pil Hong; Tae Il Kim; Won Ho Kim
Journal:  Dig Dis Sci       Date:  2012-08-17       Impact factor: 3.199

Review 4.  Outcome measures used in clinical trials for Behçet syndrome: a systematic review.

Authors:  Gulen Hatemi; Peter A Merkel; Vedat Hamuryudan; Maarten Boers; Haner Direskeneli; Sibel Z Aydin; Hasan Yazici
Journal:  J Rheumatol       Date:  2014-02-01       Impact factor: 4.666

5.  Incidence and clinical outcomes of intestinal Behçet's disease in Korea, 2011-2014: a nationwide population-based study.

Authors:  Minkyung Han; Yoon Suk Jung; Won Ho Kim; Jae Hee Cheon; Sohee Park
Journal:  J Gastroenterol       Date:  2016-12-27       Impact factor: 7.527

Review 6.  Update on the Treatment of Behcet's Disease of the Small Bowel with Biologic Agents.

Authors:  Yehyun Park; Jae Hee Cheon
Journal:  Curr Gastroenterol Rep       Date:  2020-03-19

7.  Clinical characteristics and risk factors of intestinal involvement in Behçet's syndrome patients: a cross-sectional study from a single center.

Authors:  Cheng-Cheng Hou; Jing-Fen Ye; Hai-Fen Ma; Jian-Long Guan
Journal:  Orphanet J Rare Dis       Date:  2021-03-17       Impact factor: 4.123

8.  Anti-TNF-α agents for refractory intestinal Behçet's disease: case series and meta-analysis.

Authors:  Shukai Zhan; Caiguang Liu; Na Li; Tong Li; Zhenyi Tian; Min Zhao; Dongxuan Wu; Minhu Chen; Zhirong Zeng; Xiaojun Zhuang
Journal:  Therap Adv Gastroenterol       Date:  2022-09-03       Impact factor: 4.802

Review 9.  Outcome predictors for intestinal Behçet's disease.

Authors:  Jae Jun Park; Won Ho Kim; Jae Hee Cheon
Journal:  Yonsei Med J       Date:  2013-09       Impact factor: 2.759

10.  Evidence-based diagnosis and clinical practice guidelines for intestinal Behçet's disease 2020 edited by Intractable Diseases, the Health and Labour Sciences Research Grants.

Authors:  Kenji Watanabe; Satoshi Tanida; Nagamu Inoue; Reiko Kunisaki; Kiyonori Kobayashi; Masakazu Nagahori; Katsuhiro Arai; Motoi Uchino; Kazutaka Koganei; Taku Kobayashi; Mitsuhiro Takeno; Fumiaki Ueno; Takayuki Matsumoto; Nobuhisa Mizuki; Yasuo Suzuki; Tadakazu Hisamatsu
Journal:  J Gastroenterol       Date:  2020-05-07       Impact factor: 7.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.